Circadian Rhythm as a Novel Therapeutic Target in the Intensive Care Unit

昼夜节律作为重症监护病房的新型治疗目标

基本信息

  • 批准号:
    9902193
  • 负责人:
  • 金额:
    $ 17.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-04-09 至 2022-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Candidate: My long-term career goal is to be an independent patient-oriented researcher who will improve outcomes in the intensive care unit (ICU) by investigating questions and developing interventions at the intersection of sleep physiology, circadian biology, and critical illness. I have proposed career development activities that will prepare me to successfully conduct a series of investigations focused on understanding ICU circadian rhythm abnormalities and the associated effects on ICU sleep disruption, delirium, and broader critical illness outcomes. I have relevant clinical training in critical care and sleep medicine. I have gained initial patient-oriented research experience by conducting several studies related to sleep disruption in the ICU. In this K23 application, I am proposing specific training in circadian biology with a focus on (1) circadian rhythm measurement, (2) circadian entrainment interventions, and (3) longitudinal data analysis. Completion of these training activities will bridge current knowledge gaps and set up future success as an independent investigator. Mentors and Environment: I will be mentored by Drs. Henry Klar Yaggi, Margaret Pisani, and Nancy Redeker, a team of experienced, committed experts in the fields of sleep medicine, critical care medicine, circadian measurement, ICU delirium, and patient-oriented research. This team has demonstrated collaborative success, and each member brings unique expertise. I will also work with advisors Dr. Kenneth Wright (circadian biology expert) and Dr. Terrence Murphy (analytics expert). My department Chairperson (Dr. Gary Desir) and Section Chief (Dr. Naftali Kaminski) have provided assurance that I will dedicate at least 75% of my time to career development activities. We will recruit study subjects from the Yale-New Haven Hospital Medical ICU which is a high volume ICU with sufficient patients to make this project feasible. Our section's Translational Research Core and Medical ICU Biorepository will support this project. Mentored Research Project: Delirium affects 50-80% of medical ICU patients. Prevention and treatment strategies are limited, and delirium is associated with poor outcomes including increased mortality. Because ICU sleep disruption is likely to be a contributor to the development of ICU delirium, sleep promotion is recommended for delirium treatment and prevention. Currently, there is a lack of investigation regarding the potentially significant contribution of circadian abnormalities to the problem of ICU sleep disruption and consequent delirium. Circadian abnormalities are potentially modifiable, and thus constitute a novel therapeutic target for ICU delirium. This project will prospectively study ICU patients (N=100) with detailed circadian measures. We will examine the impact of ICU light levels on circadian abnormalities and examine the association between circadian abnormalities and days of delirium. In addition, we will conduct a pilot randomized controlled trial (N=50) to assess the feasibility of providing daytime bright light to ICU patients to promote circadian entrainment.
项目摘要 候选人:我的长期职业目标是成为一名独立的、以病人为导向的研究人员, 通过调查问题和制定干预措施, 睡眠生理学、昼夜节律生物学和危重疾病的交叉点。我建议职业发展 这些活动将使我做好准备,成功地进行一系列调查,重点是了解ICU 昼夜节律异常及其对ICU睡眠中断、谵妄和更广泛的 重大疾病的结果。我接受过重症监护和睡眠医学的相关临床培训。我已经获得了 通过在ICU进行几项与睡眠中断相关的研究,获得了以患者为导向的研究经验。在 在K23的应用中,我建议进行生物节律方面的具体培训,重点是(1)生物节律 测量,(2)昼夜节律夹带干预,和(3)纵向数据分析。完成这些 培训活动将弥补目前的知识差距,并为今后作为独立调查员取得成功奠定基础。 导师和环境:我将由亨利克拉亚吉博士,玛格丽特皮萨尼和南希指导 Redeker是一个经验丰富的团队,致力于睡眠医学,重症监护医学, 昼夜节律测量、ICU谵妄和面向患者的研究。这个团队已经证明了 合作成功,每个成员都带来了独特的专业知识。我还将与顾问肯尼思博士 赖特(昼夜节律生物学专家)和特伦斯墨菲博士(分析专家)。主任医师(Dr. 加里德西尔)和科长(Naftali Kaminski博士)已经提供了保证,我将投入至少75% 我的职业发展活动的时间。我们将从耶鲁纽黑文医院招募研究对象 医疗ICU是一个高容量的ICU,有足够的病人使这个项目可行。我们的部门 转化研究核心和医学ICU生物储存库将支持该项目。 指导研究项目:谵妄影响50-80%的内科ICU患者。预防和治疗 治疗策略有限,谵妄与不良结局相关,包括死亡率增加。因为 ICU睡眠中断可能是ICU谵妄发生的一个因素,促进睡眠是 推荐用于治疗和预防谵妄。目前,缺乏关于 昼夜节律异常对ICU睡眠中断问题的潜在重要贡献, 随之而来的精神错乱昼夜节律异常可能是可改变的,因此构成了一种新的治疗方法。 目标是重症监护室精神错乱本项目将前瞻性研究ICU患者(N=100), 措施我们将检查ICU光照水平对昼夜节律异常的影响,并检查 昼夜节律异常和谵妄天数之间的关系。此外,我们会进行一个试点, 一项随机对照试验(N=50),旨在评估为ICU患者提供日间强光的可行性, 促进昼夜节律的变化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MELISSA P KNAUERT其他文献

MELISSA P KNAUERT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MELISSA P KNAUERT', 18)}}的其他基金

Reestablishing Sleep and Circadian Alignment in Medically Critically Ill Patients via a Mechanistic Randomized Controlled Trial of an ICU Sleep Chronobundle (ReAlign-ICU)
通过 ICU 睡眠时间束的机械随机对照试验 (ReAlign-ICU) 重建重症患者的睡眠和昼夜节律一致性
  • 批准号:
    10586548
  • 财政年份:
    2023
  • 资助金额:
    $ 17.49万
  • 项目类别:
Novel Circadian Biomarkers in Medical ICU Patients
内科 ICU 患者的新型昼夜节律生物标志物
  • 批准号:
    10491371
  • 财政年份:
    2021
  • 资助金额:
    $ 17.49万
  • 项目类别:
Novel Circadian Biomarkers in Medical ICU Patients
内科 ICU 患者的新型昼夜节律生物标志物
  • 批准号:
    10187053
  • 财政年份:
    2021
  • 资助金额:
    $ 17.49万
  • 项目类别:
Circadian Rhythm as a Novel Therapeutic Target in the Intensive Care Unit
昼夜节律作为重症监护病房的新型治疗目标
  • 批准号:
    10438282
  • 财政年份:
    2018
  • 资助金额:
    $ 17.49万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 17.49万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.49万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 17.49万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.49万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 17.49万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.49万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 17.49万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 17.49万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 17.49万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.49万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了